C. diff Clinical Trial Starting in November

If you have C. diff, you may want to get involved in this.  Although I am only disclosing publicly available information, I know about it because the antibodies were made by my former company, and licensed to Merck & Co. for the Phase III study in 2009 (I have no financial or any other interest in it, my former company or Merck, just to be clear - this is about the science and helping anyone with this issue).  The Phase II results were very good: http://www.nejm.org/doi/full/10.1056/NEJMoa0907635#t=article Top

If you are interested, this is the site where study sites and other contact information will eventually be posted - for now, there is no contact information or site info, but keep checking back:
http://clinicaltrials.gov/ct2/show/NCT01241552?term=difficil e+antibody&rank=4

Here are excerpts from the paper:

Results

Among the 200 patients who were enrolled (101 in the antibody group and 99 in the placebo group), the rate of recurrence of C. difficile infection was lower among patients treated with monoclonal antibodies (7% vs. 25%; 95% confidence interval, 7 to 29; P